Lithium succinate

Lithium succinate

Systematic (IUPAC) name
lithium butanedioic acid
Clinical data
AHFS/Drugs.com	monograph
Identifiers
ATC code	D11AX04 (WHO)
PubChem	CID 10197702
ChemSpider	8373202
Chemical data
Formula	C4H5LiO4
Molar mass	124.02 g/mol
SMILES [Li+].[Li+].[O-]C(=O)CCC([O-])=O
InChI InChI=1S/C4H6O4.2Li/c5-3(6)1-2-4(7)8;;/h1-2H2,(H,5,6)(H,7,8);;/q;2*+1/p-2 Key:WAHQBNXSPALNEA-UHFFFAOYSA-L
(verify)

Lithium succinate, the lithium salt of succinic acid, is a drug used in the treatment of seborrhoeic dermatitis^[1] and proposed for the treatment of anogenital warts.^[2]

References

1. Leeming JP (1993). "Use of topical lithium succinate in the treatment of seborrhoeic dermatitis". Dermatology (Basel) 187 (2): 149–50. doi:10.1159/000247228. PMID 8358107.
2. Ward KA, Armstrong KD, Maw RD, Winther MD, Gilburt SJ, Dinsmore WW (1997). "A pilot study to investigate the treatment of anogenital warts with Topical Lithium Succinate cream (8% lithium succinate, 0.05% zinc sulphate)". International journal of STD & AIDS 8 (8): 515–7. doi:10.1258/0956462971920677. PMID 9259500.